SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SEBI orders forensic audit of Venmax Drugs and Pharmaceuticals

19 Dec 2017 Evaluate

The Securities and Exchange Board of India (SEBI) has ordered forensic audit of Venmax Drugs and Pharmaceuticals (VDPL), which figures in the list of suspected shell companies. The order is to check misuse of funds even as the regulator lifted trading curbs imposed on it. The regulator has directed the exchange to appoint an independent forensic auditor.

VDPL is among the firms against whom SEBI initiated action on August 7 by ordering trading restrictions after it received the list of 331 suspected shell companies from the government.

Venmax Drugs and Pharmaceuticals (formerly known as Yenkey Drugs and Pharmaceuticals) manufactures and sells pharmaceuticals and drugs in India. It trades in bulk drugs, intermediates, and biotech products.


Venmax Drugs&Pharma Share Price

26.05 1.39 (5.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×